How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit.
How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit.
复制标题
DOI：
10.1177/1932296820978399
复制
发表时间：
2021-03
影响因子：
5
通讯作者：
Klonoff DC
中科院分区：
文献类型：
--
作者：
Zhang JY;Shang T;Ahn D;Chen K;Coté G;Espinoza J;Mendez CE;Spanakis EK;Thompson B;Wallia A;Wisk LE;Kerr D;Klonoff DC
由严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)病毒引发的2019年新冠肺炎大流行迅速席卷全球，暴露出公共卫生与来自临床、科学、监管、制药以及医疗器械和技术界的其他利益攸关方之间迫切需要合作。为了探讨如何最好地保护糖尿病患者免受新冠肺炎严重后果的影响，糖尿病技术学会与三生糖尿病研究所合作，于2020年8月26-27日主办了“国际新冠肺炎与糖尿病虚拟峰会”。这一独特的、史无前例的实时会议汇集了来自六大洲的医生、科学家、政府官员、监管专家、行业代表和糖尿病患者，共同回顾和分析新冠肺炎与糖尿病之间的关系。超过800名与会者登录。峰会由五个部分组成：(I)主题报告，(II)准备，(III)反应，(IV)恢复，和(V)监督；八个部分：(A)背景，(B)复原力，(C)门诊护理，(D)住院护理，(E)资源，(F)高危群体，(G)监管，和(H)未来；和24个部分：(1)历史流行病及其对社会的影响，(2)新冠肺炎的病理生理/风险因素，(3)新冠肺炎的社会决定因素，(4)对未来的准备，(5)药物和疫苗，(6)患者和照顾者的心理，(7)糖尿病的门诊治疗和非药物干预，(8)糖尿病门诊患者的技术和远程保健，(9)住院患者的技术，(10)新冠肺炎对糖尿病患者的管理，(11)伦理，(12)诊断测试的准确性，(13)儿童，(14)怀孕，(15)新冠肺炎的护理经济学，(16)行业的作用，(17)医护人员的保护，(18)糖尿病患者，(19)国际社会对新冠肺炎的反应，(20)政府政策，(21)测试和治疗的监管，(22)数字健康技术，(23)大数据统计，以及24)患者监控和隐私。两位主旨演讲题为(1)新冠肺炎与糖尿病--迎接挑战和(2)糖尿病与新冠肺炎的知识差距与研究机遇。虽然会议的重点是糖尿病及其与新冠肺炎的互动，但小组成员也从总体上讨论了新冠肺炎大流行。这次会议为医学、科学、政府和工业专家之间的合作产生了许多新的想法，以开发新的技术和疾病治疗范例来抗击这一全球流行病。
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has rapidly involved the entire world and exposed the pressing need for collaboration between public health and other stakeholders from the clinical, scientific, regulatory, pharmaceutical, and medical device and technology communities. To discuss how to best protect people with diabetes from serious outcomes from COVID-19, Diabetes Technology Society, in collaboration with Sansum Diabetes Research Institute, hosted the “International COVID-19 and Diabetes Virtual Summit” on August 26-27, 2020. This unique, unprecedented real-time conference brought together physicians, scientists, government officials, regulatory experts, industry representatives, and people with diabetes from six continents to review and analyze relationships between COVID-19 and diabetes. Over 800 attendees logged in. The summit consisted of five sessions: (I) Keynotes, (II) Preparedness, (III) Response, (IV) Recovery, and (V) Surveillance; eight parts: (A) Background, (B) Resilience, (C) Outpatient Care, (D) Inpatient Care, (E) Resources, (F) High-Risk Groups, (G) Regulation, and (H) The Future; and 24 sections: (1) Historic Pandemics and Impact on Society, (2) Pathophysiology/Risk Factors for COVID-19, (3) Social Determinants of COVID-19, (4) Preparing for the Future, (5) Medications and Vaccines, (6) Psychology of Patients and Caregivers, (7) Outpatient Treatment of Diabetes Mellitus and Non-Pharmacologic Intervention, (8) Technology and Telehealth for Diabetes Outpatients, (9) Technology for Inpatients, (10) Management of Diabetes Inpatients with COVID-19, (11) Ethics, (12) Accuracy of Diagnostic Tests, (13) Children, (14) Pregnancy, (15) Economics of Care for COVID-19, (16) Role of Industry, (17) Protection of Healthcare Workers, (18) People with Diabetes, (19) International Responses to COVID-19, (20) Government Policy, (21) Regulation of Tests and Treatments, (22) Digital Health Technology, (23) Big Data Statistics, and 24) Patient Surveillance and Privacy. The two keynote speeches were entitled (1) COVID-19 and Diabetes—Meeting the Challenge and (2) Knowledge Gaps and Research Opportunities for Diabetes and COVID-19. While there was an emphasis on diabetes and its interactions with COVID-19, the panelists also discussed the COVID-19 pandemic in general. The meeting generated many novel ideas for collaboration between experts in medicine, science, government, and industry to develop new technologies and disease treatment paradigms to fight this global pandemic.
登录
查看更多内容
影响因子：
5
作者：
Bode, Bruce;Garrett, Valerie;Klonoff, David C.
通讯作者：
Klonoff, David C.
影响因子：
5.1
作者：
Aragona M;Rodia C;Bertolotto A;Campi F;Coppelli A;Giannarelli R;Bianchi C;Dardano A;Del Prato S
通讯作者：
Del Prato S
DOI：
10.1007/s40615-020-00844-1
发表时间：
2020-08-13
影响因子：
3.9
作者：
Arasteh, Kamyar
通讯作者：
Arasteh, Kamyar
影响因子：
7.2
作者：
Alexander, Paul Elias;Debono, Victoria Borg;Alhazzani, Waleed
通讯作者：
Alhazzani, Waleed
影响因子：
64.5
作者：
Bouhaddou, Mehdi;Memon, Danish;Krogan, Nevan J.
通讯作者：
Krogan, Nevan J.